These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 21267033)

  • 21. Schnitzler Syndrome With Response to Anakinra Monotherapy: 7 Years of Follow-up.
    Hidalgo-García Y; García-Fernández E; Palacio-Aller L; Gonzalvo P
    Actas Dermosifiliogr; 2017 Dec; 108(10):956-958. PubMed ID: 28728792
    [No Abstract]   [Full Text] [Related]  

  • 22. The Schnitzler syndrome: chronic urticaria in disguise: a single-centre report of 11 cases and a critical reappraisal of the literature.
    Vanderschueren S; van der Veen A
    Clin Exp Rheumatol; 2017; 35(1):69-73. PubMed ID: 27606610
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Occurrence of Rheumatoid Arthritis in a Patient Treated with Anakinra for Schnitzler Syndrome: A Case Report.
    Margerin F; Gottenberg JE; Lipsker D
    J Rheumatol; 2016 Jul; 43(7):1447. PubMed ID: 27371651
    [No Abstract]   [Full Text] [Related]  

  • 24. Treatment of Schnitzler's syndrome with anakinra.
    Gilson M; Abad S; Larroche C; Dhote R
    Clin Exp Rheumatol; 2007; 25(6):931. PubMed ID: 18173934
    [No Abstract]   [Full Text] [Related]  

  • 25. Striking effect of the IL-1 receptor antagonist anakinra in chronic urticarial rash with polyclonal increase in IgA and IgG.
    Treudler R; Kauer F; Simon JC
    Acta Derm Venereol; 2007; 87(3):280-1. PubMed ID: 17533504
    [No Abstract]   [Full Text] [Related]  

  • 26. A Man With Recurrent Fever, Episodic Rash, and Pain.
    Aslam F; Wiedmeier JE; DiCaudo DJ
    Arthritis Care Res (Hoboken); 2021 Aug; 73(8):1106-1113. PubMed ID: 31961498
    [No Abstract]   [Full Text] [Related]  

  • 27. Anakinra: an effective treatment in the Schnitzler syndrome.
    Vandenhende MA; Bentaberry F; Morlat P; Bonnet F
    Joint Bone Spine; 2011 Dec; 78(6):636-7. PubMed ID: 21550281
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Refractory urticaria and the importance of diagnosing Schnitzler's syndrome.
    Nham T; Saleh C; Chu D; Vakaljan SL; Ohayon JA; Siegal DM
    BMJ Case Rep; 2019 Apr; 12(4):. PubMed ID: 31036740
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Successful canakinumab treatment identifies IL-1β as a pivotal mediator in Schnitzler syndrome.
    de Koning HD; Schalkwijk J; van der Meer JW; Simon A
    J Allergy Clin Immunol; 2011 Dec; 128(6):1352-4. PubMed ID: 21704363
    [No Abstract]   [Full Text] [Related]  

  • 30. Schnitzler syndrome: treatment failure to rituximab but response to anakinra.
    Eiling E; Möller M; Kreiselmaier I; Brasch J; Schwarz T
    J Am Acad Dermatol; 2007 Aug; 57(2):361-4. PubMed ID: 17467852
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Schnitzler's syndrome: successful treatment with anakinra.
    Crouch R; Akhras V; Sarkany R
    Australas J Dermatol; 2007 Aug; 48(3):178-81. PubMed ID: 17680970
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Schnitzler syndrome: a dramatic improvement with anakinra.
    Wastiaux H; Barbarot S; Gagey-Caron V; Berthelot JM; Hamidou M; Stalder JF
    J Eur Acad Dermatol Venereol; 2009 Jan; 23(1):85-7. PubMed ID: 18355191
    [No Abstract]   [Full Text] [Related]  

  • 33. Schnitzler Syndrome Without a Monoclonal Gammopathy: A Case Report.
    Urbanski M; Holfeld K; Milne A; Abbas M
    J Cutan Med Surg; 2016 Nov; 20(6):575-578. PubMed ID: 27358310
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Schnitzler's syndrome: a case report and literature review of the response to treatment with anakinra].
    Benítez Gutiérrez L; Mellor Pita S; Tutor de Ureta P; Yebra Bango M
    Med Clin (Barc); 2013 May; 140(9):427-8. PubMed ID: 23177777
    [No Abstract]   [Full Text] [Related]  

  • 35. Genetic predisposition (NLRP3 V198M mutation) for IL-1-mediated inflammation in a patient with Schnitzler syndrome.
    Loock J; Lamprecht P; Timmann C; Mrowietz U; Csernok E; Gross WL
    J Allergy Clin Immunol; 2010 Feb; 125(2):500-2. PubMed ID: 20159265
    [No Abstract]   [Full Text] [Related]  

  • 36. [Schnitzler's syndrome].
    Henry B; Néel A; Barbarot S; Masseau A; Hamidou M
    Rev Med Interne; 2013 Apr; 34(4):224-9. PubMed ID: 23357692
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interleukin-1 receptor antagonist (anakinra) for Schnitzler syndrome.
    Sönnichsen A; Saulite I; Mangana J; Kerl K; Mehra T; Desislava I; Chang YT; Petrausch U; Schmid-Grendelmeier P; Hoetzenecker W; Cozzio A; Guenova E
    J Dermatolog Treat; 2016 Oct; 27(5):436-8. PubMed ID: 26864191
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Successful use of anakinra to treat refractory Schnitzler's syndrome.
    Dybowski F; Sepp N; Bergerhausen HJ; Braun J
    Clin Exp Rheumatol; 2008; 26(2):354-7. PubMed ID: 18565263
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Schnitzler syndrome: diagnostics and treatment].
    Szturz P; Adam Z; Sedivá A; Fojtík Z; Corbová D; Neubauer J; Prásek J; Hájek R; Mayer J
    Klin Onkol; 2011; 24(4):271-7. PubMed ID: 21905617
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chronic urticarial eruption associated with monoclonal gammopathy.
    Barbosa NS; Schoch JJ; Ringler MD; Wetter DA
    Am J Hematol; 2015 Apr; 90(4):365-6. PubMed ID: 25329746
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.